Cargando…
The microcirculatory characteristics of the heart and lung meridians: Study protocol clinical trial (SPIRIT Compliant)
INTRODUCTION: The aim of the present study is to compare the microcirculatory difference of different meridians by using laser doppler flowmetry and investigate the specificity for the meridian-visceral association and site-to-site association between 2 specific meridians. METHODS AND ANALYSIS: The...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220657/ https://www.ncbi.nlm.nih.gov/pubmed/32243379 http://dx.doi.org/10.1097/MD.0000000000019594 |
_version_ | 1783533211870035968 |
---|---|
author | Hu, Hantong Jiang, Yongliang Li, Xiaoyu Lou, Jiali Zhang, Yajun He, Xiaofen Fang, Junfan Wu, Yuanyuan Shao, Xiaomei Fang, Jianqiao |
author_facet | Hu, Hantong Jiang, Yongliang Li, Xiaoyu Lou, Jiali Zhang, Yajun He, Xiaofen Fang, Junfan Wu, Yuanyuan Shao, Xiaomei Fang, Jianqiao |
author_sort | Hu, Hantong |
collection | PubMed |
description | INTRODUCTION: The aim of the present study is to compare the microcirculatory difference of different meridians by using laser doppler flowmetry and investigate the specificity for the meridian-visceral association and site-to-site association between 2 specific meridians. METHODS AND ANALYSIS: The Lung and Heart meridians are chosen as 2 specific studied meridians. 120 participants will be enrolled and divided into the healthy control group, chronic stable angina pectoris group and healthy intervention group. Laser doppler flowmetry will be used to assess the blood perfusion of the Heart and Lung meridians. The specificity for the meridian-visceral association will be investigated by comparing the microcirculatory difference between the Heart and Lung meridians in the healthy control group and chronic stable angina pectoris group. Besides, participants in the healthy intervention group will receive 2 sessions of moxibustion in the Heart meridian and Lung meridian, respectively, to explore the specificity for the site-to-site association on the body surface. Primary outcomes will be blood flow curve and blood perfusion units of relevant sites along the Heart and Lung meridians. Statistical analysis will be conducted by third party statisticians. ETHICS AND DISSEMINATION: Ethics approval (approval No: ZSLL-KY-2019-001A-01) has been obtained from the Ethics Committee of the Third Affiliated Hospital of Zhejiang Chinese Medical University. The study findings will be disseminated through presentation at peer-reviewed medical journals. TRIAL REGISTRATION: ClinicalTrials.gov NCT04244812. |
format | Online Article Text |
id | pubmed-7220657 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Wolters Kluwer Health |
record_format | MEDLINE/PubMed |
spelling | pubmed-72206572020-06-15 The microcirculatory characteristics of the heart and lung meridians: Study protocol clinical trial (SPIRIT Compliant) Hu, Hantong Jiang, Yongliang Li, Xiaoyu Lou, Jiali Zhang, Yajun He, Xiaofen Fang, Junfan Wu, Yuanyuan Shao, Xiaomei Fang, Jianqiao Medicine (Baltimore) 3800 INTRODUCTION: The aim of the present study is to compare the microcirculatory difference of different meridians by using laser doppler flowmetry and investigate the specificity for the meridian-visceral association and site-to-site association between 2 specific meridians. METHODS AND ANALYSIS: The Lung and Heart meridians are chosen as 2 specific studied meridians. 120 participants will be enrolled and divided into the healthy control group, chronic stable angina pectoris group and healthy intervention group. Laser doppler flowmetry will be used to assess the blood perfusion of the Heart and Lung meridians. The specificity for the meridian-visceral association will be investigated by comparing the microcirculatory difference between the Heart and Lung meridians in the healthy control group and chronic stable angina pectoris group. Besides, participants in the healthy intervention group will receive 2 sessions of moxibustion in the Heart meridian and Lung meridian, respectively, to explore the specificity for the site-to-site association on the body surface. Primary outcomes will be blood flow curve and blood perfusion units of relevant sites along the Heart and Lung meridians. Statistical analysis will be conducted by third party statisticians. ETHICS AND DISSEMINATION: Ethics approval (approval No: ZSLL-KY-2019-001A-01) has been obtained from the Ethics Committee of the Third Affiliated Hospital of Zhejiang Chinese Medical University. The study findings will be disseminated through presentation at peer-reviewed medical journals. TRIAL REGISTRATION: ClinicalTrials.gov NCT04244812. Wolters Kluwer Health 2020-04-03 /pmc/articles/PMC7220657/ /pubmed/32243379 http://dx.doi.org/10.1097/MD.0000000000019594 Text en Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
spellingShingle | 3800 Hu, Hantong Jiang, Yongliang Li, Xiaoyu Lou, Jiali Zhang, Yajun He, Xiaofen Fang, Junfan Wu, Yuanyuan Shao, Xiaomei Fang, Jianqiao The microcirculatory characteristics of the heart and lung meridians: Study protocol clinical trial (SPIRIT Compliant) |
title | The microcirculatory characteristics of the heart and lung meridians: Study protocol clinical trial (SPIRIT Compliant) |
title_full | The microcirculatory characteristics of the heart and lung meridians: Study protocol clinical trial (SPIRIT Compliant) |
title_fullStr | The microcirculatory characteristics of the heart and lung meridians: Study protocol clinical trial (SPIRIT Compliant) |
title_full_unstemmed | The microcirculatory characteristics of the heart and lung meridians: Study protocol clinical trial (SPIRIT Compliant) |
title_short | The microcirculatory characteristics of the heart and lung meridians: Study protocol clinical trial (SPIRIT Compliant) |
title_sort | microcirculatory characteristics of the heart and lung meridians: study protocol clinical trial (spirit compliant) |
topic | 3800 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7220657/ https://www.ncbi.nlm.nih.gov/pubmed/32243379 http://dx.doi.org/10.1097/MD.0000000000019594 |
work_keys_str_mv | AT huhantong themicrocirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant AT jiangyongliang themicrocirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant AT lixiaoyu themicrocirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant AT loujiali themicrocirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant AT zhangyajun themicrocirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant AT hexiaofen themicrocirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant AT fangjunfan themicrocirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant AT wuyuanyuan themicrocirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant AT shaoxiaomei themicrocirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant AT fangjianqiao themicrocirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant AT huhantong microcirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant AT jiangyongliang microcirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant AT lixiaoyu microcirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant AT loujiali microcirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant AT zhangyajun microcirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant AT hexiaofen microcirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant AT fangjunfan microcirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant AT wuyuanyuan microcirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant AT shaoxiaomei microcirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant AT fangjianqiao microcirculatorycharacteristicsoftheheartandlungmeridiansstudyprotocolclinicaltrialspiritcompliant |